Tumor Microenvironment Characterized in Human Multiple Primary Lung Cancers
Complete the form below to unlock access to ALL audio articles.
A research group led by Prof. PIAO Hailong from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences (CAS) and their collaborators have characterized the cellular composition and spatial architecture of the tumor microenvironment in human multiple primary lung cancers (MPLCs) by integrating single-cell RNA-seq and spatial transcriptomics.
MPLCs refer to several primary tumors growing synchronously in the lung. With the widespread of high-resolution computed tomography, MPLCs are being diagnosed more frequently. However, it is still difficult to distinguish MPLC and intrapulmonary metastasis (IPM) in the clinic, especially in cases of similar histologies.
In this study, the researchers conducted integrative analysis of both single-cell transcriptome and spatial transcriptome data based on bioinformatics and machine learning methods.
They identified a previously undescribed sub-population of epithelial cells termed CLDN2+ alveolar type II (AT2), specifically enriched in MPLCs. Possessing a relatively stationary state, this subtype played an important role in cellular communication, aggregating spatially in tumor tissues and dominating the malignant histopathological patterns.
The researchers verified that the CLDN2 protein expression could help distinguish MPLCs from intrapulmonary metastasis and solitary lung cancer.
In addition, they found a cell surface receptor TNFRSF18/GITR highly expressed in T cells of MPLCs, which suggested that TNFRSF18 was one potential immunotherapeutic target in MPLCs.
Reference: Wang Y, Chen D, Liu Y, et al. Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers. Cell Death Dis. 2023;14(7):1-16. doi: 10.1038/s41419-023-05992-w
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.